BRIEF published on 03/04/2024 at 15:49, 8 months 16 days ago The Vanguard Group, Inc. Discloses Interest in Ageas SA/NV Form 8.3 The Vanguard Group Takeover Code Share Ownership Ageas SA/NV
PRESS RELEASE published on 03/04/2024 at 15:44, 8 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.44% stake in Ageas SA/NV as of 01 March 2024 in accordance with Rule 8.3 of the Takeover Code Securities The Vanguard Group, Inc. Form 8.3 Disclosure Ageas SA/NV
BRIEF published on 02/29/2024 at 16:26, 8 months 20 days ago The Vanguard Group, Inc. Reports Ownership in Ageas SA/NV The Vanguard Group Takeover Code Ownership Disclosure Financial Investment Ageas SA/NV
PRESS RELEASE published on 02/29/2024 at 16:21, 8 months 20 days ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.44% stake in Ageas SA/NV as of 28 Feb 2024. Direct Line Insurance Group plc also involved in disclosure The Vanguard Group Financial Disclosure Stake Disclosure Ageas SA/NV Direct Line Insurance Group Plc
Published on 11/21/2024 at 14:00, 16 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 16 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 16 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 46 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 41 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 1 minute ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 18 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 56 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 31 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 31 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
